CEREBRO participates in Sweet Biopharma Day 2026

Mirabel, QC - This week, on April 29, took place Sweet Biopharma Day 2026, which brought together some of Canada’s most promising early-stage biotech companies for a day of high-impact networking and innovation. Held in Mirabel, this invitation-only event showcased 16 selected start-ups—the “Sweet 16”—to leading pharmaceutical companies, investors, and key players across the life sciences ecosystem.

CEREBRO Therapeutics was proud to be among this year’s selected cohort. As a company focused on developing transformative therapies for neurodegenerative diseases, CEREBRO had the opportunity to present its platform and vision to an audience of global industry leaders. This opportunity allowed us to make new connections and to build relationships within the vibrant Canadian biotech ecosystem.

As we continue to advance our programs, events like this play a critical role in cultivating the relationships needed to bring next-generation therapies to patients. We thank the organizers and sponsors for this insightful event!